DOACs use linked to bleeding in hepatocellular carcinoma: Study Dr. Shravani Dali9 Aug 2021 3:30 PM GMTThe presence of hepatocellular carcinoma is tied with major bleeding, suggests a study published in the Clinical Gastroenterology and Hepatology. ...
SGLT2 inhibitors improve survival over DPP4i in patients with cirrhosis and diabetes: Study Medha20 July 2021 6:15 AM GMTPatients with cirrhosis needing additional pharmacotherapy for diabetes beyond metformin experience increased survival with SGLT2i in relation to DPP4i...
How excess sugar intake causes fatty liver disease, decode IIT Mandi researchers Hina Zahid15 Jun 2021 4:30 AM GMTA team of researchers from the Indian Institute of Technology (IIT), Mandi has unravelled the molecular mechanism by which excess sugar consumption...
Vitamin D may help protect spontaneous peritonitis in cirrhosis patients: Study Medha2 Jun 2021 6:00 AM GMTChina: Vitamin D may protect from spontaneous peritonitis in cirrhosis patients, finds a recent study in Gastroenterology Review.Portal hypertension, a...
High blood sugar tied to progression of cirrhosis in chronic hepatitis C: Study MD Bureau26 April 2021 5:55 AM GMTHepatitis C virus (HCV) mainly affects the liver, but also several tissues outside the liver have been reported to be involved, resulting in a wide...
Statins lower risk of advanced liver fibrosis in diabetes patients: Study Medha20 March 2021 2:50 AM GMTItaly: Statin use lowers the risk of cirrhosis and advanced liver fibrosis in type 2 diabetes (T2D) patients, finds a recent study in the journal Metab...
Beta-blockers may reduce infection risk in cirrhosis patients: Study Medha12 March 2021 3:24 PM GMTUSA: The use of non-selective beta-blockers at home lowered overall risk of infections in cirrhosis patients, according to the study published in the...
Terlipressin improves renal outcomes in hepatorenal syndrome: CONFIRM Study Dr Kartikeya Kohli10 March 2021 4:45 AM GMTHepatorenal syndrome (HRS) is a fatal complication of advanced cirrhosis with ascites and liver failure, with nearly 50% of patients dying within...
Carvedilol improves survival in cirrhosis patients: Study Medha5 March 2021 3:15 AM GMTUK: The use of carvedilol improves overall survival in patients with cirrhosis and portal hypertension, finds a recent study in the journal&n...
Rifaximin may prevent hepatic encephalopathy after TIPS in patients with cirrhosis Hina Zahid1 Feb 2021 11:30 PM GMTIn a randomized controlled trial, the antibiotic rifaximin used before and after transjugular intrahepatic portosystemic shunt (TIPS) placement, a...
Carvedilol tied to improved survival in cirrhosis patients: Study Medha27 Jan 2021 9:37 AM GMTUK: Carvedilol improves survival in patients with cirrhosis and portal hypertension, suggests a recent study in the journal Alimentary Pharmacology &am...
Frailty linked to higher mortality for women awaiting liver transplants Hina Zahid3 Jan 2021 11:30 AM GMTWomen awaiting liver transplants in the United States are known to be about one-third more likely than men to become too ill to undergo surgery or die ...
